By |

Profile

Celyad SA is a biopharmaceutical company, specialized in cell therapy. It develops technologies and treatments to treat severe diseases with poor prognosis. The company focuses on Immuno oncology, Cardiology, and Medical devices. Its main product candidates include CAR-T NKR-2, C-Cure. The firm has CYAD-01, CYAD-02, CYAD-03 programs in pipeline. The company owns trademarks and service marks including CELYAD, C-CATH, C_CURE, CATH and C-CATHez and CARDIO 3 BIOSCIENCES. The firm has Cardiology and Immuno-oncology operating segments. It derives majority of its revenues from Immuno-oncology segment.

Contact Information

Website: www.celyad.com
Email: investors@celyad.com
Main Phone: +32 10394100
Address: Rue Edouard Belin 2
City / Town: Mont-Saint-Guibert
Country: BEL
Postal Code: 1435

Issuer Information

Exchange: NSD
CEO: Filippo Petti
Employees: 96


Gathering Data... Please wait

Profile

Celyad SA is a biopharmaceutical company, specialized in cell therapy. It develops technologies and treatments to treat severe diseases with poor prognosis. The company focuses on Immuno oncology, Cardiology, and Medical devices. Its main product candidates include CAR-T NKR-2, C-Cure. The firm has CYAD-01, CYAD-02, CYAD-03 programs in pipeline. The company owns trademarks and service marks including CELYAD, C-CATH, C_CURE, CATH and C-CATHez and CARDIO 3 BIOSCIENCES. The firm has Cardiology and Immuno-oncology operating segments. It derives majority of its revenues from Immuno-oncology segment.

Contact Information

Website: www.celyad.com
Email: investors@celyad.com
Main Phone: +32 10394100
Address: Rue Edouard Belin 2
City / Town: Mont-Saint-Guibert
Country: BEL
Postal Code: 1435

Issuer Information

Exchange: NSD
CEO: Filippo Petti
Employees: 96
$ 13.35 $ -5.41 (-28.84%)
Last Price 13.35 Change $ -5.41 Change % -28.84 Tick N/A
Bid 13.35 Bid Size 100.00 Ask 13.59 Ask Size 900.00
Open 14.37 High 14.74 Low 13.00 Prev Close 18.76
Last Trade Volume 33,384 52 Wk Hi 32.18 52 Wk Low 15.36
Market Cap 159.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 11,942,344.00 EPS (TTM) -3.86 PE Ratio N/A Exchange NSD
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 74 74 74 74
Low Target Price Estimate 49 74 74 49
Mean Target Price Estimate 61.5 74 74 61.5
Standard Deviation 17.68 0 0 17.68
Date of Most Recent Estimate 05/31/18 03/23/18 03/23/18 05/31/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1